Coping with breast cancer: a cluster analytic approach Thomas F. HackLesley F. Degner OriginalPaper Pages: 185 - 194
Adjustment to breast cancer: age‐related differences in coping and emotional distress Bruce E. CompasMiriam Frankel StollDavid N. Krag OriginalPaper Pages: 195 - 203
Association of angiogenesis and poor prognosis in node‐positive patients receiving anthracycline‐based adjuvant chemotherapy P. ViensJ. JacquemierD. Maraninchi OriginalPaper Pages: 205 - 212
Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost Sue‐Anne McLachlanMelania PintilieIan F. Tannock OriginalPaper Pages: 213 - 223
Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience Massimo CristofanilliFrankie Ann HolmesGabriel N. Hortobagyi OriginalPaper Pages: 225 - 233
Tissue inhibitor of metalloprotease (TIMP)‐1 and proliferative behaviour of clonal breast cancer cells Claudio LuparelloGrazia AvanzatoIda Pucci‐Minafra OriginalPaper Pages: 235 - 244
The Fas/Fas‐ligand system: a mechanism for immune evasion in human breast carcinomas Linda S. GutierrezMariel ElizaGil Mor OriginalPaper Pages: 245 - 253
Association between endometrial cancer and tamoxifen treatment of breast cancer Christian Peters‐EnglWilhelm FrankMichael Medl OriginalPaper Pages: 255 - 260
Incremental cost‐effectiveness of double‐reading mammograms Tiina LeivoTiina SalminenOlli‐Pertti Heinonen OriginalPaper Pages: 261 - 267
Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin Cheppail RamachandranWei You OriginalPaper Pages: 269 - 278